Vasculitis patients wanted for major 5-Year observation study
NCT ID NCT04413331
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is following 670 adults with vasculitis, a rare blood vessel disease, for up to 5 years. Researchers will collect medical data and blood samples to see how the disease starts, how it is treated, and what long-term problems may arise. No new treatments are being tested—this is purely an effort to learn more about the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict how vasculitis behaves and which treatments work best for different patients.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only, so it cannot directly improve patient health. Results may take years and may not lead to clear changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de médecine interne, Hôpital Cochin, AP-HP
RECRUITINGParis, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could an arthritis drug shrink dangerous brain aneurysms?
- New study aims to spot eye damage early in rare vasculitis patients
- Massive study reveals hidden dangers of common steroid treatments
- 10-Year vasculitis study aims to predict relapses and improve care
- Scientists track prednisolone levels to improve dosing for inflammatory conditions
- Blood samples could unlock secrets of autoimmune diseases